Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94143


Purpose:

The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma


Criteria:

Inclusion Criteria: - Histologically or cytologically confirmed renal cell carcinoma containing predominant clear cell histology - Failed or intolerant to 1 or more previous lines of treatments (which must include a Tyrosine Kinase Inhibitor) Exclusion Criteria: - Collecting duct histology - A history of bleeding disorders or currently taking oral vitamin K antagonise medication - Unstable brain metastases - History of prior or concomitant malignancy (except for curatively treated non-melanoma skin cancer or carcinoma in situ of the cervix, or other cancer for which the patient has been disease free for 3 years)


NCT ID:

NCT00740441


Primary Contact:

Principal Investigator
Greg Smith, MD
Saint Francis Memorial Hospital


Backup Contact:

N/A


Location Contact:

San Francisco, California 94143
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.